RespireRx Pharmaceuticals Market Cap

RespireRx Pharmaceuticals has a market cap or net worth of $292.34 thousand as of April 19, 2024. Its market cap has decreased by -86.08% in one year.

Market Cap

292.34K

Enterprise Value

2.50M

1-Year Change

-86.08%

Ranking

n/a

Market Cap Chart

Since December 1, 1998, RespireRx Pharmaceuticals's market cap has decreased from $3.90M to $292.34K, a decrease of -92.50%. That is a compound annual growth rate of -10.57%.

Market Cap History

Date	Market Cap	% Change
Feb 2, 2022	1.30M	8.33%
Feb 1, 2022	1.20M	-
Jan 31, 2022	1.20M	-
Jan 28, 2022	1.20M	-
Jan 27, 2022	1.20M	-25.00%
Jan 26, 2022	1.60M	-
Jan 25, 2022	1.60M	23.08%
Jan 24, 2022	1.30M	-7.14%
Jan 21, 2022	1.40M	-6.67%
Jan 20, 2022	1.50M	25.00%
Jan 19, 2022	1.20M	-
Jan 18, 2022	1.20M	-
Jan 14, 2022	1.20M	-
Jan 13, 2022	1.20M	-
Jan 12, 2022	1.20M	-
Jan 11, 2022	1.20M	-7.69%
Jan 10, 2022	1.30M	-7.14%
Jan 7, 2022	1.40M	-12.50%
Jan 6, 2022	1.60M	14.29%
Jan 5, 2022	1.40M	-
Jan 4, 2022	1.40M	7.69%
Jan 3, 2022	1.30M	18.18%
Dec 31, 2021	1.10M	-
Dec 30, 2021	1.10M	-21.43%
Dec 29, 2021	1.40M	-

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	690.55B
Novo Nordisk	547.04B
UnitedHealth Group	462.01B
Johnson & Johnson	356.43B
Merck & Co.	318.56B
AbbVie	294.65B
AstraZeneca	212.49B
Thermo Fisher	207.95B

Market Cap Rankings